Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.1600
-0.0056 (-3.38%)
At close: Jun 9, 2026, 4:00 PM EDT
0.1623
+0.0023 (1.44%)
After-hours: Jun 9, 2026, 7:58 PM EDT
Gossamer Bio Employees
As of December 31, 2025, Gossamer Bio had 162 total employees, including 161 full-time and 1 part-time employees. The number of employees increased by 17 or 11.72% compared to the previous year.
Employees
162
Change (1Y)
17
Growth (1Y)
11.72%
Revenue / Employee
$342,821
Profits / Employee
-$1,113,556
Market Cap
37.55M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 162 | 17 | 11.72% | 161 | 1 |
| Dec 31, 2024 | 145 | 10 | 7.41% | 144 | 1 |
| Dec 31, 2023 | 135 | -43 | -24.16% | 135 | 0 |
| Dec 31, 2022 | 178 | -7 | -3.78% | 178 | 0 |
| Dec 31, 2021 | 185 | -11 | -5.61% | 185 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| aTyr Pharma | 60 |
| Plus Therapeutics | 28 |
| RenovoRx | 17 |
| Atossa Therapeutics | 16 |
| Nutriband | 13 |
| Actuate Therapeutics | 12 |
| Hyperion DeFi | 9 |
| Genenta Science | 9 |
GOSS News
- 19 hours ago - Gossamer Bio Proxy statement: Proxy filing - Filings
- 6 days ago - Gossamer Bio announces early tender results, early settlement of solicitation - TheFly
- 6 days ago - Gossamer Bio, Inc. Announces Early Tender Results and Early Settlement for Exchange Offer and Consent Solicitation with Respect to Existing Convertible Notes - Business Wire
- 7 days ago - Gossamer Bio announces extension of early tender date for exchange offer - TheFly
- 7 days ago - Gossamer Bio, Inc. Announces Extension of Early Tender Date for Exchange Offer and Consent Solicitation with Respect to Existing Convertible Notes - Business Wire
- 11 days ago - Investors Sue Gossamer Bio (GOSS) Over Inflated High Blood Pressure Study Claims - TipRanks
- 20 days ago - Goldman Sachs suspends rating on Gossamer Bio - TheFly
- 21 days ago - Gossamer Bio price target lowered to 28c from 30c at Barclays - TheFly